Progress in Research on Tumor Metastasis Inhibitors.
Tumor metastasis is a significant cause of malignant cancer related death and is the primary factor affecting the prognosis of malignant tumors. It refers to the process of a malignant tumor transferring from the primary site to a secondary organ or tissue. Tumor metastasis is a dynamic process involving many factors and multi-stage development, such as cancer and microenvironment, the various interactions in the body. The process of metastasis is complex and difficult to control and formed tumor thrombus in the end is more tricky. As such, inhibiting tumor metastasis is an effective means of treating malignant tumors. There have been several theories on the development of tumor metastasis. In recent years, more emerging theories have provided more treatments for tumor metastasis. In this article, we will describe the therapeutic targets and related drugs for tumor metastasis. Besides, increasing our understanding of the molecular mechanisms that govern tumor metastasis is very important and can reveal new anti-cancer targets. Cell adhesion and invasion, angiogenesis and so on are the critical points in this process. Signal transduction and tumor microenvironment is getting more attention recently. In addition, there are many unknown targets waiting for us to explore. We will introduce the relative targets and some mechanisms respectively in the following paragraphs. We looked up some anti-tumor metastasis drugs in Food and Drug Administration, and these drugs target at their respective cancer. We also consulted some drugs in clinical research. This article will discuss breakthroughs in this area and the corresponding recent developments in anti-cancer drug discovery.